market_competition

Indianapolis – September 29, 2026 -- Eli Lilly and Company (NYSE: LLY) reported that its oral GLP-1 drug Foundayo (orforglipron) at 17.2 mg produced 1.5% greater weight loss and 0.3% greater A1C reduction than oral semaglutide 25 mg over 52 weeks in adults with type 2 diabetes, based on an indirect treatment comparison presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan.

Indirect analysis draws on ACHIEVE-3 and PIONEER PLUS trial data

The comparison, covariate-adjusted for gender, age, baseline A1C and baseline weight, found weight-loss differences ranging from 1.5% to 2.4% and A1C reductions of 0.3% to 0.6% in favor of Foundayo 17.2 mg across multiple statistical methods. The 95% confidence interval for weight loss was -2.7% to -0.2%, and for A1C reduction was -0.6% to -0.1%.

Las Vegas – – September 16, 2026 -- The obesity therapeutics market across the seven major markets was valued at approximately USD 16 billion in 2025 and is projected to grow at a 27% CAGR through 2036, according to DelveInsight, as a wave of next-generation candidates threatens to disrupt the Eli Lilly-Novo Nordisk duopoly.

Oral GLP-1 Therapies Accelerate Patient Uptake

Novo Nordisk's oral WEGOVY surpassed 5 million cumulative U.S. prescriptions within 30 weeks of launch, while Eli Lilly's oral FOUNDAYO (orforglipron) gained significant traction among patients initiating obesity treatment by mid-2026. Aparna Thakur, Project Manager of Forecasting & Analytics at DelveInsight, said FOUNDAYO's once-daily oral formulation positions it for rapid uptake as a more convenient alternative to injectable therapies.

Halle – September 10, 2026 -- The insolvent chemical producer Leuna Polyamid has failed to secure a binding investor offer for its large plant in Leuna, Saxony-Anhalt, putting roughly 400 jobs at risk of permanent loss.

No binding investor offer has been received, CEO confirms

"We have unfortunately not yet received a binding offer from an investor," managing director Martin Naundorf told the Mitteldeutsche Zeitung. The company had been searching for a buyer to keep the polyamide and fertilizer production site operational.

Production continues through September to fulfill existing customer orders

The plant will keep running until the end of September to complete outstanding customer contracts, according to Naundorf. After that, management plans to shut down the facility itself, a process expected to take 15 to 20 days.

Singapore – September 10, 2026 -- More than half of consumers across Europe's five largest telecom markets are open to switching mobile providers, according to new analysis from Circles, exposing widening cracks in traditional customer retention strategies.

53% of consumers across France, Germany, Italy, Spain and the UK are open to switching operators

The Consumer Insights: Customer Stickiness & Loyalty in European Telecommunications report finds switching intention varies sharply by country, age and exposure to low-cost rivals, undermining the case for a single pan-European retention playbook.